These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Clinical evaluation of CA 19-9, TPA, IAP and 5'-NPD-V as tumor markers of hepatocellular, bile duct and pancreas carcinoma].
    Author: Takahashi H, Miyazaki H, Deura M, Shimizu Y, Asukata I, Kameda H.
    Journal: Gan No Rinsho; 1985 May; 31(6 Suppl):623-30. PubMed ID: 2411964.
    Abstract:
    The serum level of CA 19-9 elevated exponentially in gastrointestinal carcinoma and the specificity of CA 19-9 was extraordinarily high. The sensitivity of CA 19-9 to pancreas, bile duct, hepatocellular and metastatic liver carcinoma was 75%, 79%, 22%, and 82% each. TPA seems to be useful as a screening tumor maker of gastrointestinal carcinoma, because the sensitivity was very high (84%) in every gastrointestinal carcinoma. IAP increased in pancreas and bile duct carcinoma and reflected immunological status of tumor bearing host. 5'-NPD-V was useful tumor marker not only of hepatocellular carcinoma but also pancreas and bile duct carcinoma.
    [Abstract] [Full Text] [Related] [New Search]